FDA Investigator Christopher Janik
Christopher Janik has inspections in 1 countries as of 05 Oct 2023. Christopher Janik has collaborated with a combinined 994 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
13
Last Inspection Date:
05 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Alysia M Salonia,
Anthony C Warchut,
Anthony N Onianwa,
Byungja E Marciante,
Christine M Smith,
Chunsheng Cai, PhD,
Cynthia F Kleppinger, MD,
Darin S Wiegers,
Deborah A Greco,
Diane C Thibodeau,
Dien N Nguyen,
Edmund F Mrak, Jr,
Eduardo L Rodriguez,
Edward J Janik,
Erik W Koester,
Gabrielle J Swain,
Hang N Guo,
Janete F Guardia,
Jason A Rossi,
John J Thibodeau,
John P Mistler,
Johnna L Bleem,
Jonah S Ufferfilge,
Jonathan G Matrisciano,
Justine M Corson,
Kenneth H Williams,
Kent A Conforti,
LCDR Chad N Thompson,
M Patriciaurphy Murphy,
Margaret M Sands,
Mark R Mcclain,
Mary Jeanet Mcgarry,
Matthew C Watson,
Maya M Davis,
Miah Jung,
Michael P Anthony,
Michelle M Noe,
Mindy M Chou,
Nealie C Newberger,
Nina Yang,
Paul E Stein,
Peter R Lenahan,
Ramon E Martinez,
Rapti D Madurawe,
Robert J Martin,
Sean R Marcsisin,
Sharon K Gershon,
Stephanie Mangigian, MS/OSH, RN,
Stephen R Souza,
Susanne M Richardson, MSc RAC ELS,
Terry Bridgewater,
Tonia F Bernard,
Tyanna N Hadley,
Victoria M Daddeo
Christopher Janik's Documents
Publish Date | Document Type | Title |
---|---|---|
March, 2017 | FDA 483 | Reliant Compounded Solutions Monroe, LLC - Form 483, 2017-03-03 |
December, 2017 | EIR | Azurity Pharmaceuticals, Inc. - EIR, 2017-12-20 |
April, 2017 | FDA 483 | Brookfield Medical/Surgical Supply, Inc. - Form 483, 2017-04-18 |
July, 2017 | EIR | Boehringer Ingelheim Pharmaceuticals, Inc. - EIR, 2017-07-28 |
June, 2017 | FDA 483 | Pfizer Laboratories Div Pfizer Inc - Form 483, 2017-06-07 |
February, 2017 | FDA 483 | Breckenridge Pharmaceutical, Inc. - Form 483, 2017-02-21 |
October, 2016 | FDA 483 | DCA, Inc. DBA Beacon Prescriptions - Form 483, 2016-10-25 |
June, 2017 | EIR | Pfizer Laboratories Div Pfizer Inc - EIR, 2017-06-07 |
February, 2017 | EIR | Breckenridge Pharmaceutical, Inc. - EIR, 2017-02-21 |
February, 2018 | FDA 483 | N-Molecular, Inc. dba SOFIE - Form 483, 2018-02-28 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more